Healthcare
LBO France acquires Idéal Résidences
LBO France has acquired a majority stake in retirement homes operator Idéal Résidences from Edmond de Rothschild Investment Partners (EdRIP) and Alliance Entreprendre.
G Square invests €15m in zahnarztzentrum.ch
Dedicated healthcare investor G Square has invested €15m in Swiss dentistry services provider zahnarztzentrum.ch.
SEED invests DKK 7.6m in Reapplix
Danish venture capital firm SEED Capital has invested DKK 7.6m in biotech company Reapplix.
KKR-owned Alliance Boots offloads pension liabilities
Alliance Boots, owned by Kohlberg Kravis Roberts (KKR) and private investor Stefano Pessina, has offloaded the pension liabilities of 3,000 former Alliance UniChem employees, according to reports.
Avenir Entreprises acquires Laboratoires Elysée
Avenir Entreprises has backed the management buy-in of Laboratoires Elysée from the Guattari group. The deal value has not been disclosed but the company will trade under its original name Balarama following the buyout.
SHS leads growth investment in phenox GmbH
SHS Gesellschaft für Beteiligungsmanagement mbH has invested an undisclosed amount in medical technology company phenox GmbH.
BioGeneration Ventures et al. invest in Arcarios
A pool of investors led by BioGeneration Ventures have provided Dutch biotechnology company Arcarios with a round of seed financing.
EQT backs MBO of Roeser Group
EQT has backed the management buyout of Roeser Group with a €50m investment from the EQT Expansion Capital II fund.
Gilde Healthcare III secures Philips commitment
The recently launched Gilde Healthcare III fund has attracted Royal Philips Electronics as a cornerstone investor.
EPS Value Plus backs CHF 10m round in Sensimed
EPS Value Plus AG has invested CHF 3.5m as part of a CHF 10m series-B financing round in micro-systems developer Sensimed.
Priveq invests in Mediplast
Priveq Investment has invested in Swedish producer of consumables for the healthcare industry Mediplast AB.
FSI et al. invest €40m in Cerenis Therapeutics
The Fund for Strategic Investment (FSI) and existing investors have provided French biopharma Cerenis Therapeutics with a тЌ40m series-C round of funding.
Riverside acquires Celvitae to boost Crioestaminal
The Riverside Company has acquired Spanish private cord blood bank Celvitae BiomУЉdica S.A. which will join its portfolio company Crioestaminal.
Longbow leads £1.7m Ambicare funding
Longbow Capital has led a ТЃ1.7m funding round in medical devices firm Ambicare Health.
Oséo backs Cerenis and Novasep with €10.7m
The French government's venture arm OsУЉo has invested тЌ10.7m in healthcare companies Cerenis Therapeutics and Groupe Novasep.
NBGI Private Equity acquires Praticdose
NBGI Private Equity has backed the management buy-in of French medical equipment provider Praticdose.
High-Tech Gründerfonds et al. invest €400,000 in Chromotek
High-Tech GrУМnderfonds and Bayern Kapital have provided biotechnology company Chromotek with тЌ400,000.
Edmond de Rothschild et al. invest €16m in Poxel
Edmond de Rothschild Investment Partners (EdRIP), CDC Entreprises and CrУЉdit Agricole Private Equity have provided biopharma Poxel with a тЌ16m series-A round of financing.
Crédit Agricole PE et al. invest €7.5m in EyeTechCare
CrУЉdit Agricole PE and insurance company SHAM have provided medical devices developer EyeTechCare with a тЌ7.5m round of funding.
STING invests SEK 2m in ENCare
STING has injected SEK 2m in Swedish MedTech company ENCare.
EQT sells Aleris to Investor AB
EQT Partners has agreed to sell Aleris Holding AB to Investor AB for an enterprise value of SEK 4.4bn.
Waterland ups stake in Arseus
Waterland Private Equity has increased its stake in medical supplies and services company Arseus.
Life sciences: testing times ahead?
Pharmaceuticals and biotechnology have fared marginally better than other sectors during the global recession, but the last two years have still been lacklustre for private equity investments in life sciences. However, with a healthy number of deals already...
Vækstfonden provides funding for EntomoPharm
VУІkstfonden has taken a stake in EntomoPharm for an undisclosed amount.